Mikako Nishida

Immune-mediated antitumor effect by type 2 diabetes drug, metformin

Shingo Eikawa, Mikako Nishida, Shusaku Mizukami et al. · Proceedings of the National Academy of Sciences · 2015 · 535 citations · Full text

Life Sciences, Immunology, Oncology +16

Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects

Takenori Uehara, Shingo Eikawa, Mikako Nishida et al. · International Immunology · 2018 · 118 citations · Full text

Life Sciences, Immunology, Oncology +17

Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes

Mikako Nishida, Nahoko Yamashita, Taisaku Ogawa et al. · Journal for ImmunoTherapy of Cancer · 2021 · 101 citations · Full text

Medicine, Oncology, Pharmacology +17

The Antinociceptive and Anti-inflammatory Action of the CHCl3-Soluble Phase and Its Main Active Component, Damnacanthal, Isolated from the Root of Morinda citrifolia

Kanako Okusada, Kazuo Nakamoto, Mikako Nishida et al. · Biological and Pharmaceutical Bulletin · 2011 · 29 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Metformin-ROS-Nrf2 connection in the host defense mechanism against oxidative stress, apoptosis, cancers, and ageing

Heiichiro Udono, Mikako Nishida · Biochimica et Biophysica Acta (BBA) - General Subjects · 2022 · 28 citations

Life Sciences, Oncology, Pharmacology +16